Medtox Laboratories is an established biotechnology and healthcare company, founded in 1983. Based in the United States, the company operates a full-service clinical laboratory along with a SAMHSA-certified drug testing laboratory. On the clinical side, Medtox provides testing services to various health care organizations including physician offices, Clinical Trials sponsors, occupational health clinics, and pain management clinics. They also offer testing services for corporations, clinics, and governmental agencies on the drug testing front. Currently, there is no publicly available information on the last investment or associated investors. As a biotechnology and healthcare company, Medtox Laboratories occupies a vital space given the increasing emphasis on healthcare and wellness. Their diverse range of testing services catering to clinical, occupational, and drug testing needs positions them as a key player in the industry. With their established presence since 1983, they have a proven track record and experience in the field. Overall, Medtox Laboratories has a strong foundation and a broad customer base in both clinical and drug testing services. For potential investors, exploring opportunities for scaling, technological innovations, and market expansion could be potential areas of interest. As the healthcare and biotechnology industries continue to evolve, Medtox Laboratories could present an attractive investment opportunity for those looking to capitalize on the growing demand for healthcare-related services.
There is no investment information
No recent news or press coverage available for Medtox Laboratories.